vs
波士顿科学(MLSS)与AIRWA INC.(YYAI)财务数据对比。点击上方公司名可切换其他公司
AIRWA INC.的季度营收约是波士顿科学的1.5倍($3.0M vs $2.1M),AIRWA INC.净利率更高(-7.4% vs -53.0%,领先45.6%),AIRWA INC.同比增速更快(729.8% vs 2.2%),过去两年AIRWA INC.的营收复合增速更高(14.3% vs -4.3%)
波士顿科学公司是源自美国的跨国生物医疗企业,专业研发生产介入医疗领域医疗器械,产品覆盖介入放射学、介入心脏病学、外周介入治疗、神经调控、神经血管介入、电生理、心脏外科、血管外科、内镜、肿瘤学、泌尿与妇科等多个领域。
Flying W航空公司(FWA)起源于1961年,创始人在新泽西开设了Flying W机场,打造可通航降落的度假胜地,在20世纪60年代末70年代初曾是知名度较高的上市企业。该公司押注阿拉斯加石油开发,1969年发展至巅峰,吸引了马特拉克家族投资,还吸纳两名好莱坞演员加入董事会,并收购了阿拉斯加的Red Dodge航空,购入飞机借阿拉斯加输油管道项目谋求发展。
MLSS vs YYAI — 直观对比
营收规模更大
YYAI
是对方的1.5倍
$2.1M
营收增速更快
YYAI
高出727.6%
2.2%
净利率更高
YYAI
高出45.6%
-53.0%
两年增速更快
YYAI
近两年复合增速
-4.3%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $2.1M | $3.0M |
| 净利润 | $-1.1M | $-221.8K |
| 毛利率 | 73.0% | 75.2% |
| 营业利润率 | -52.5% | 1.8% |
| 净利率 | -53.0% | -7.4% |
| 营收同比 | 2.2% | 729.8% |
| 净利润同比 | 46.4% | 83.8% |
| 每股收益(稀释后) | — | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
MLSS
YYAI
| Q4 25 | $2.1M | $3.0M | ||
| Q3 25 | $2.4M | $3.0M | ||
| Q2 25 | $2.3M | $3.0M | ||
| Q1 25 | $2.2M | $3.3M | ||
| Q4 24 | $2.0M | $3.3M | ||
| Q3 24 | $2.5M | $3.3M | ||
| Q2 24 | $1.9M | $-701.1K | ||
| Q1 24 | $2.2M | — |
净利润
MLSS
YYAI
| Q4 25 | $-1.1M | $-221.8K | ||
| Q3 25 | $-1.2M | $1.3M | ||
| Q2 25 | $-1.5M | $552.2K | ||
| Q1 25 | $-2.0M | $-411.2K | ||
| Q4 24 | $-2.0M | $-1.4M | ||
| Q3 24 | $-1.5M | $-4.2M | ||
| Q2 24 | $223.6K | — | ||
| Q1 24 | $-1.4M | — |
毛利率
MLSS
YYAI
| Q4 25 | 73.0% | 75.2% | ||
| Q3 25 | 69.5% | 75.2% | ||
| Q2 25 | 69.6% | 75.2% | ||
| Q1 25 | 73.8% | 77.3% | ||
| Q4 24 | 75.0% | 77.3% | ||
| Q3 24 | 73.0% | 77.3% | ||
| Q2 24 | 76.1% | — | ||
| Q1 24 | 74.5% | — |
营业利润率
MLSS
YYAI
| Q4 25 | -52.5% | 1.8% | ||
| Q3 25 | -48.1% | 49.7% | ||
| Q2 25 | -63.9% | 42.7% | ||
| Q1 25 | -89.5% | 16.2% | ||
| Q4 24 | -101.4% | 71.2% | ||
| Q3 24 | -58.4% | 74.6% | ||
| Q2 24 | -96.0% | — | ||
| Q1 24 | -65.1% | — |
净利率
MLSS
YYAI
| Q4 25 | -53.0% | -7.4% | ||
| Q3 25 | -48.9% | 42.0% | ||
| Q2 25 | -63.8% | 18.4% | ||
| Q1 25 | -89.3% | -12.6% | ||
| Q4 24 | -101.1% | -41.7% | ||
| Q3 24 | -58.1% | -129.0% | ||
| Q2 24 | 12.1% | — | ||
| Q1 24 | -64.1% | — |
每股收益(稀释后)
MLSS
YYAI
| Q4 25 | — | $-0.05 | ||
| Q3 25 | $-0.01 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-1.41 | ||
| Q4 24 | — | $6.43 | ||
| Q3 24 | $-0.02 | $-1.91 | ||
| Q2 24 | — | $-30.98 | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.1M | $107.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.8M | $165.4M |
| 总资产 | $7.8M | $172.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
MLSS
YYAI
| Q4 25 | $1.1M | $107.0M | ||
| Q3 25 | $1.3M | $2.5M | ||
| Q2 25 | $1.3M | $1.4M | ||
| Q1 25 | $2.2M | $4.3M | ||
| Q4 24 | $3.3M | $18.1M | ||
| Q3 24 | $4.8M | $18.2M | ||
| Q2 24 | $5.8M | $1.8M | ||
| Q1 24 | $5.0M | — |
股东权益
MLSS
YYAI
| Q4 25 | $2.8M | $165.4M | ||
| Q3 25 | $2.5M | $26.2M | ||
| Q2 25 | $3.3M | $25.3M | ||
| Q1 25 | $4.5M | $26.1M | ||
| Q4 24 | $5.8M | $8.0M | ||
| Q3 24 | $7.2M | $9.4M | ||
| Q2 24 | $8.0M | $9.6M | ||
| Q1 24 | $7.5M | — |
总资产
MLSS
YYAI
| Q4 25 | $7.8M | $172.1M | ||
| Q3 25 | $8.5M | $34.7M | ||
| Q2 25 | $8.1M | $32.9M | ||
| Q1 25 | $9.1M | $30.7M | ||
| Q4 24 | $9.8M | $21.6M | ||
| Q3 24 | $11.2M | $23.2M | ||
| Q2 24 | $12.0M | $23.2M | ||
| Q1 24 | $11.4M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-226.1K | $-30.8M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
MLSS
YYAI
| Q4 25 | $-226.1K | $-30.8M | ||
| Q3 25 | $81.8K | $-1.1M | ||
| Q2 25 | $-1.8M | $-423.7K | ||
| Q1 25 | $-1.0M | $-133.8K | ||
| Q4 24 | $-1.5M | $779.4K | ||
| Q3 24 | $-973.9K | $-601.3K | ||
| Q2 24 | $783.7K | $-460.3K | ||
| Q1 24 | $-1.2M | — |
现金转化率
MLSS
YYAI
| Q4 25 | — | — | ||
| Q3 25 | — | -0.86× | ||
| Q2 25 | — | -0.77× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.50× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图